Investor Relations

About Tempramed

TempraMed is a leading medical device technology company transforming medication management for individuals with chronic conditions. Its innovative solutions combine advanced hardware and digital technologies to protect temperature-sensitive medications and empower patients with unprecedented health control.

Leveraging patented temperature control technology and sophisticated digital platforms, TempraMed ensures medication potency, enables precise tracking, and facilitates information sharing between patients, caregivers, and healthcare providers.

Download Investor Presentation

Download Fact Sheet

Patented Technology

The company’s cutting-edge devices protect critical medications while simplifying treatment management. Committed to improving patient outcomes, TempraMed bridges the gap between medical device engineering and digital health innovation. The company provides intuitive solutions that help patients with chronic conditions live more confidently.

Why Invest

Untapped Market Potential:

Over 160 million patients use temperature sensitive medications every day globally; $30BN total addressable market (TAM).

Proprietary, Patented Technology:

9 patents globally. Space grade technology that keeps medication at optimal temperatures. Four products in market with protective storage solution that is compact, hassle-free and user friendly, battery free, works 24/7/365, no maintenance required. Over hundreds of thousands of VIVI Caps sold to date, ~30% of customers repeat buys, high customer satisfaction rate.

Global Distribution Capabilities:

Manufactured and assembled in the USA with current production capacity of 1M units/year (~US$70 million in sales). Global distribution partnerships in Korea, Turkey, Israel, Benelux and growing.

Strong Validation & Market Adoption:

Distribution with large pharmacy, government and retail networks including: Humana, CVS, Walmart, Walgreens, Amazon, McKesson, Target, US Department of Veteran Affairs.